Tevogen Bio

(NASDAQ) TVGN

Current Price$10.09

Market Cap$41.43M

Since IPO (2022)-98%

5 YearN/A

1 Year-84%

1 Month+2%

Tevogen Bio Financials at a Glance

Market Cap

$41.43M

Revenue (TTM)

$0.00

Net Income (TTM)

-$21.35M

EPS (TTM)

-$5.84

P/E Ratio

-1.68

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$10.09

Volume

342

Open

$10.18

Price

$10.09

Volume

342

Open

$10.18

Previous Close

$10.09

Daily Range

$9.47 - $10.18

52-Week Range

$4.14 - $71.00

Estimated Earnings Date

Aug 13, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$10.09

Volume

342

Open

$10.18

Previous Close

$10.09

Daily Range

$9.47 - $10.18

52-Week Range

$4.14 - $71.00

Estimated Earnings Date

Aug 13, 2026

TVGN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tevogen Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Ryan Saadi, MD

Website

www.tevogen.com

Headquarters

Warren, NJ 07059, US

TVGN Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

241.39%

Return on Capital

N/A

Return on Assets

-433.95%

Earnings Yield

-59.52%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$41.43M

Shares Outstanding

4.22M

Volume

342

Avg. Volume

29.42K

Financials (TTM)

Gross Profit

-$144.84K

Operating Income

-$21.19M

EBITDA

-$20.83M

Operating Cash Flow

-$11.75M

Capital Expenditure

-$64.43K

Free Cash Flow

-$11.82M

Cash & ST Invst.

$692.31K

Total Debt

$3.07M

Tevogen Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$59.05K

N/A

Gross Margin

0.00%

N/A

Market Cap

$41.43M

N/A

Market Cap/Employee

$2.30M

N/A

Employees

N/A

Net Income

-$5.45M

+47.5%

EBITDA

-$5.46M

+46.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$692.31K

-64.9%

Total Debt

$3.07M

-36.3%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$1.09M

-63.5%

Short Term Debt

$1.98M

+8.6%

Return on Assets

-4.34%

N/A

Return on Invested Capital

9.02%

N/A

Free Cash Flow

-$2.73M

+17.4%

Operating Cash Flow

-$2.73M

+17.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TILInstil Bio, Inc.

TILInstil Bio, Inc.$7.56+0.00%

CLNNClene Inc.

CLNNClene Inc.$5.77-2.04%

ATOSAtossa Therapeutics, Inc.

ATOSAtossa Therapeutics, Inc.$1.90+3.83%

ONCYOncolytics Biotech Inc.

ONCYOncolytics Biotech Inc.$0.94+2.58%

CGTXCognition Therapeutics, Inc.

CGTXCognition Therapeutics, Inc.$1.65-1.79%

HURATuHURA Biosciences, Inc.

HURATuHURA Biosciences, Inc.$2.64-2.58%

SRZNSurrozen, Inc.

SRZNSurrozen, Inc.$24.86+5.07%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$16.14+0.00%

SOFISoFi Technologies

SOFISoFi Technologies$17.29+0.01%

NOKNokia

NOKNokia$13.70-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.44-0.10%

PFEPfizer

PFEPfizer$24.72-0.01%

TAT&T

TAT&T$22.81+0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.56+0.10%

Questions About TVGN

What is the current price of Tevogen Bio?

Tevogen Bio is trading at $10.09 per share.

What is the 52-week range for Tevogen Bio?

Over the past 52 weeks, Tevogen Bio has traded between $4.14 and $71.00.

How much debt does Tevogen Bio have?

As of the most recent reporting period, Tevogen Bio reported total debt of $9.47M.

How much cash does Tevogen Bio have on hand?

Tevogen Bio reported $692.31K in cash and cash equivalents in its most recent financial results.

What is Tevogen Bio’s dividend yield?

Tevogen Bio does not currently have a dividend yield.

Tevogen Bio

Tevogen Bio Financials at a Glance

TVGN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Tevogen Bio

TVGN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Tevogen Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TVGN

What is the current price of Tevogen Bio?

What is the 52-week range for Tevogen Bio?

How much debt does Tevogen Bio have?

How much cash does Tevogen Bio have on hand?

What is Tevogen Bio’s dividend yield?

Premium Investing Services